| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 14, 2023 | Sale | $41.05 | 7,598 | 311,898 | 4,902 | Dec 15, 2023, 09:50 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 13, 2023 | Sale | $24.46 | 28,804 | 704,485 | 29,951 | Dec 15, 2023, 05:38 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 13, 2023 | Sale | $41.05 | 7,598 | 311,898 | 4,902 | Dec 15, 2023, 05:38 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Nov 25, 2022 | Option Exercise | $18.72 | 4,114 | 77,028 | 25,630 | Nov 28, 2022, 08:41 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Nov 23, 2022 | Sale | $34.33 | 2,057 | 70,610 | 23,573 | Nov 28, 2022, 08:41 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 08, 2021 | Option Exercise | $3.67 | 2,057 | 7,549 | 25,630 | Dec 10, 2021, 04:20 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Mar 17, 2021 | Option Exercise | $19.49 | 100 | 1,949 | 100 | Jun 04, 2021, 07:20 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Oct 28, 2020 | Option Exercise | $3.76 | 2,057 | 7,734 | 23,573 | Oct 29, 2020, 04:20 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 04, 2019 | Option Exercise | $3.56 | 2,057 | 7,323 | 21,516 | Dec 06, 2019, 05:12 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 14, 2018 | Option Exercise | $3.07 | 2,057 | 6,315 | 19,459 | Dec 18, 2018, 04:06 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Jun 14, 2018 | Option Exercise | $4.89 | 11,086 | 54,156 | 20,258 | Jun 15, 2018, 07:32 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Aug 10, 2017 | Buy | $2.78 | 7,500 | 20,836 | 12,500 | Aug 14, 2017, 06:07 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Aug 08, 2017 | Buy | $3.00 | 5,000 | 15,002 | 5,000 | Aug 10, 2017, 07:58 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Dec 06, 2016 | Option Exercise | $4.44 | 16,748 | 74,411 | 16,431 | Dec 08, 2016, 04:52 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Nov 04, 2015 | Option Exercise | $6.33 | 5,452 | 34,520 | 6,041 | Nov 06, 2015, 05:20 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Jan 07, 2015 | Option Exercise | $8.68 | 4,450 | 38,648 | 3,497 | Jan 21, 2015, 08:13 PM | |
| XENE | Xenon Pharmaceuticals Inc. | PATOU GARY | Director | Jan 07, 2015 | Option Exercise | $4.98 | 3,497 | 17,415 | 3,497 | Jan 09, 2015, 08:30 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Aug 07, 2014 | Sale | $55.21 | 40,000 | 2,208,458 | 20,000 | Aug 08, 2014, 04:31 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Jul 14, 2014 | Sale | $46.51 | 59,700 | 2,776,646 | 30,000 | Jul 15, 2014, 02:10 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | May 12, 2014 | Option Exercise | $40.24 | 20,000 | 804,900 | 10,000 | May 13, 2014, 06:46 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | May 09, 2014 | Option Exercise | $38.51 | 40,000 | 1,540,324 | 20,000 | May 13, 2014, 06:46 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Oct 01, 2013 | Sale | $25.26 | 40,000 | 1,010,600 | 20,000 | Oct 04, 2013, 04:57 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Jul 01, 2013 | Option Exercise | $15.43 | 60,000 | 925,800 | 30,000 | Jul 02, 2013, 04:47 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Jul 02, 2013 | Sale | $15.81 | 20,000 | 316,100 | 10,000 | Jul 02, 2013, 04:47 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Apr 12, 2013 | Option Exercise | $15.81 | 20,000 | 316,100 | 10,000 | Apr 16, 2013, 02:49 PM | |
| PCRX | Pacira Pharmaceuticals, Inc. | PATOU GARY | Chief Medical Officer | Apr 01, 2013 | Sale | $14.88 | 60,000 | 892,891 | 30,000 | Apr 03, 2013, 12:53 PM |
Menu